Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative

@article{Cai2016AntimicrobialPF,
  title={Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative},
  author={Tommaso Cai and Luca Gallelli and Andrea Cocci and Daniele Tiscione and Paolo Verze and Michele Lanciotti and Davide Vanacore and Michele Rizzo and Mauro Gacci and Omar M Saleh and Gianni Malossini and Giovanni Liguori and Carlo Trombetta and Damiano Rocco and Alessandro Palmieri and Riccardo Bartoletti and Marco Carini and Florian Martin Erich Wagenlehner and Kurt G. Naber and Vincenzo G Mirone and Truls Erik Bjerklund Johansen},
  journal={World Journal of Urology},
  year={2016},
  volume={35},
  pages={221-228}
}
To compare fosfomycin trometamol (FT) and ciprofloxacin (CIP) for antibiotic prophylaxis in transrectal prostate biopsy (TR-PB). Data for 1109 patients (mean age 66.7 ± 8.45) who underwent TR-PB between March to September 2015 in seven Italian urological institutions were retrospectively reviewed, of which 632 received FT (Group 1) and 477 received CIP… CONTINUE READING